-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on Pelthos Therapeutics, Lowers Price Target to $40

Benzinga·10/12/2026 19:55:50
语音播报
Lake Street analyst Thomas Flaten maintains Pelthos Therapeutics (AMEX:PTHS) with a Buy and lowers the price target from $50 to $40.